Jing He

2.6k total citations · 1 hit paper
56 papers, 1.9k citations indexed

About

Jing He is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jing He has authored 56 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 15 papers in Cancer Research and 10 papers in Immunology. Recurrent topics in Jing He's work include RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (9 papers) and Epigenetics and DNA Methylation (7 papers). Jing He is often cited by papers focused on RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (9 papers) and Epigenetics and DNA Methylation (7 papers). Jing He collaborates with scholars based in China, United States and Philippines. Jing He's co-authors include William C. Wimley, Taylor Fuselier, W. Berkeley Kauffman, Mingxia Zhou, Muxiang Zhou, Lubing Gu, Fucheng He, Chang Wang, Lei Lv and Kalina Hristova and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Jing He

55 papers receiving 1.9k citations

Hit Papers

D-mannose facilitates imm... 2022 2026 2023 2024 2022 50 100 150

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jing He 1.4k 414 375 218 153 56 1.9k
Vicente A. Torres 1.4k 1.0× 325 0.8× 241 0.6× 191 0.9× 101 0.7× 61 2.2k
Rong Zhang 1.0k 0.7× 382 0.9× 505 1.3× 280 1.3× 155 1.0× 109 2.0k
Xinggang Mao 962 0.7× 444 1.1× 277 0.7× 141 0.6× 126 0.8× 58 1.8k
Ming‐Zhong Sun 1.5k 1.1× 549 1.3× 278 0.7× 366 1.7× 210 1.4× 83 2.2k
Liang Xu 1.9k 1.3× 973 2.4× 423 1.1× 325 1.5× 276 1.8× 98 2.7k
Carmela Dell’Aversana 937 0.7× 289 0.7× 172 0.5× 119 0.5× 89 0.6× 40 1.4k
Deding Tao 795 0.6× 427 1.0× 394 1.1× 144 0.7× 80 0.5× 69 1.3k
Nam‐ho Huh 1.2k 0.8× 361 0.9× 218 0.6× 212 1.0× 130 0.8× 65 1.8k
Qiaoming Zhi 1.5k 1.1× 1.0k 2.5× 452 1.2× 200 0.9× 176 1.2× 79 2.2k
Dawn Maynard 1.4k 1.0× 233 0.6× 294 0.8× 192 0.9× 115 0.8× 23 2.3k

Countries citing papers authored by Jing He

Since Specialization
Citations

This map shows the geographic impact of Jing He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing He more than expected).

Fields of papers citing papers by Jing He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing He. The network helps show where Jing He may publish in the future.

Co-authorship network of co-authors of Jing He

This figure shows the co-authorship network connecting the top 25 collaborators of Jing He. A scholar is included among the top collaborators of Jing He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing He. Jing He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chang, Dan Du, Jie Yin, et al.. (2025). CircNF1 modulates the progression and immune evasion of esophageal squamous cell carcinoma through dual regulation of PD-L1. Cellular & Molecular Biology Letters. 30(1). 37–37. 5 indexed citations
2.
He, Jing, Dan Du, Xue Wang, et al.. (2025). Deciphering the secret codes in N7‐methylguanosine modification: Context‐dependent function of methyltransferase‐like 1 in human diseases. Clinical and Translational Medicine. 15(2). e70240–e70240. 3 indexed citations
3.
He, Jing, et al.. (2023). D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the progression of NSCLC. Oncogene. 42(47). 3503–3513. 4 indexed citations
4.
Zhou, Mingxia, Jing He, Yingxia Li, et al.. (2023). N6-methyladenosine modification of REG1α facilitates colorectal cancer progression via β-catenin/MYC/LDHA axis mediated glycolytic reprogramming. Cell Death and Disease. 14(8). 557–557. 24 indexed citations
5.
Li, Qiang, et al.. (2023). Analysis of synonymous codon usage patterns in mitochondrial genomes of nine Amanita species. Frontiers in Microbiology. 14. 1134228–1134228. 43 indexed citations
6.
He, Jing, Mingen Lin, Xinchao Zhang, et al.. (2023). TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential. Cell Discovery. 9(1). 84–84. 9 indexed citations
7.
Zhou, Mingxia, Dan Du, Chang Wang, et al.. (2023). EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression. Cell Death and Disease. 14(8). 559–559. 18 indexed citations
8.
Zhang, Ruonan, Yajing Yang, Wenjing Dong, et al.. (2022). D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1. Proceedings of the National Academy of Sciences. 119(8). 160 indexed citations breakdown →
9.
Li, Shuyan, Jing He, Ruonan Zhang, et al.. (2022). TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling. Cancer Research. 82(11). 2097–2109. 34 indexed citations
10.
Li, Xiaoyan, ZhengMing Wu, Jing He, et al.. (2021). OGT regulated O-GlcNAcylation promotes papillary thyroid cancer malignancy via activating YAP. Oncogene. 40(30). 4859–4871. 46 indexed citations
11.
He, Jing, Mingxia Zhou, Xiaoyan Li, et al.. (2020). SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms. Oncogene. 39(13). 2658–2675. 38 indexed citations
12.
He, Jing, et al.. (2017). UBAP2L silencing inhibits cell proliferation and G2/M phase transition in breast cancer. Breast Cancer. 25(2). 224–232. 26 indexed citations
13.
Ma, Hua, Yimeng Wang, Helong Wang, et al.. (2017). MicroRNA-20b promotes the accumulation of CD11b+Ly6G+Ly6C<sup>low</sup> myeloid-derived suppressor cells in asthmatic mice. Central European Journal of Immunology. 42(1). 30–38. 9 indexed citations
14.
He, Jing, Mingxia Zhou, Xinfeng Chen, et al.. (2016). Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 35(1). 98–98. 72 indexed citations
15.
Kauffman, W. Berkeley, Taylor Fuselier, Jing He, & William C. Wimley. (2015). Mechanism Matters: A Taxonomy of Cell Penetrating Peptides. Trends in Biochemical Sciences. 40(12). 749–764. 269 indexed citations
16.
Kyrychenko, Alexander, Jing He, William C. Wimley, & Alexey S. Ladokhin. (2014). Structural Plasticity in the Topology of Membrane-Spanning Domain of HIV-1 gp41. Biophysical Journal. 106(2). 507a–507a. 1 indexed citations
17.
Cui, Tanxing, David D. Mowrey, Vasyl Bondarenko, et al.. (2011). NMR structure and dynamics of a designed water-soluble transmembrane domain of nicotinic acetylcholine receptor. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1818(3). 617–626. 26 indexed citations
18.
He, Jing, Kai Wang, Andrew C. Edmondson, et al.. (2010). Gene-based interaction analysis by incorporating external linkage disequilibrium information. European Journal of Human Genetics. 19(2). 164–172. 17 indexed citations
19.
Huang, Shuhong, Jing He, Xiaoli Zhang, et al.. (2006). Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis. 27(7). 1334–1340. 203 indexed citations
20.
He, Jing, et al.. (2005). Dendritic cells in germ-free and specific pathogen-free mice have similar phenotypes and in vitro antigen presenting function. Immunology Letters. 102(1). 16–24. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026